Endpoints News’ John Carroll and DealForma’s Chris Dokomajilar hosted a special webinar to discuss their latest ranking of the top 100 biotech VCs, examining the challenges and opportunities in a market facing an IPO drought and investor hesitancy. Listen to the webinar here.